作者:A.-mohsen M.E. Omar、N.S. Habib、Omaima M. Aboulwafa
DOI:10.1002/jps.2600710909
日期:1982.9
Several benzimidazole and benzothiazole alkylating agents, bearing structural modification of certain drugs, were synthesized and evaluated for anticancer activity. Among the products, the dihydro-chloride salt of 2-p-[2-(bis(2-chloroethyl)amino)ethoxy]phenyl}benzimidazole (VI) exhibited a high antileukemic activity in P-388 lymphocytic leukemia.
合成了几种带有某些药物结构修饰的苯并咪唑和苯并噻唑烷基化剂,并评估了其抗癌活性。在这些产品中,2- 对-[2-(双(2-氯乙基)氨基)乙氧基]苯基}苯并咪唑(VI)的二盐酸盐在P-388淋巴细胞白血病中表现出高抗白血病活性。